EHRA Premium Access

Relation of Nonsteroidal Anti-Inflammatory Drugs and Time in Therapeutic Range in Bleeding Risk in Atrial Fibrillation: the SPORTIF Trials

Topic: Atrial Fibrillation - Stroke Prevention - Oral Anticoagulation

Congress Presentation

About the speaker

Doctor Marco Proietti

IRCCS Clinical Scientific Institute Maugeri, Milan (Italy)
6 presentations
0 follower

6 more presentations in this session

Incidence of atrial arrhythmia and uptake of anticoagulation in stroke and non-stroke populations according to arrhythmia burden; a 7-year experience.

Speaker: Doctor P. Chousou (Cambridge, GB)


Incidence and predictors of left atrial appendage thrombus in patients treated with direct oral anticoagulants versus warfarin for non-valvular atrial fibrillation

Speaker: Doctor K. Minami (Utsunomiya, JP)


Left atrial stunning as a predictor of atrial fibrillation occurrence after cryptogenic stroke

Speaker: Doctor J. Farinha (Setubal, PT)


Indications for and outcome in patients undergoing left atrial appendage closure - Results of the Austrian LAAC Registry

Speaker: Mr D. Zweiker (Vienna, AT)


Differences in anticoagulation strategy and outcome in patients with atrial fibrillation according to renal function


Access the full session

Managing the thromboembolic risk in atrial fibrillation

Speakers: Doctor M. Proietti, Doctor P. Chousou, Doctor K. Minami, Doctor J. Farinha, Mr D. Zweiker

About the event


EHRA 2018

18 March - 20 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk